The ACE Veterans Act would require the Department of Veterans Affairs to allow eligible veterans enrolled in VA health care to receive a full-year supply of prescribed contraceptive pills, transdermal patches, vaginal rings, and other contraceptive products. It also requires VA medical providers to notify veterans that this full-year dispensing option is available when they prescribe these products.
The bill defines “contraceptive product” broadly to include any drug, device, or biological product intended to prevent pregnancy, including products that may also be used for other health needs, so long as they are approved, cleared, authorized, or licensed under specified federal drug and medical product authorities. The measure adds a new section to title 38 of the U.S. Code and makes a conforming clerical amendment to the chapter’s table of contents.
Impact
If enacted, the bill would amend chapter 17 of title 38 of the U.S. Code to create a new VA benefit requiring full-year contraceptive dispensing for covered veterans, expanding access within the veterans’ health system and changing VA prescribing and pharmacy practices. It would affect veterans enrolled in annual patient enrollment under section 1705, VA clinicians who prescribe contraception, and VA pharmacies that would need to process and dispense larger quantities on request.
Sentiment
Based on the bill’s sponsorship and the absence of recorded opposition, the overall sentiment appears supportive and pro-access. The bill was introduced by a group of Democratic senators and referred to the Senate Committee on Veterans’ Affairs, suggesting it is being advanced as a veterans’ health care access measure. No committee transcript or vote history is available in the provided material, so there is no recorded debate to indicate broader support or opposition.
Contention
The main policy issue likely to generate discussion is whether veterans should be allowed to obtain a full-year supply of contraception at once, which could raise questions about pharmacy management, utilization, and implementation within VA health care. Another possible point of contention is the breadth of the definition of “contraceptive product,” which includes products used for other health needs as long as they also prevent pregnancy. No specific objections, amendments, or opposing viewpoints are included in the provided record.
Expressing support for the recognition of September 26, 2025, as "World Contraception Day" and expressing the sense of the House of Representatives regarding global and domestic access to contraception.
An Act to Require Health Insurance Coverage for Federally Approved Nonprescription Oral Hormonal Contraceptives and Nonprescription Emergency Contraceptives